A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.

In the first randomised controlled trial to investigate the use of a two-in-one inhaler as the sole reliever therapy for ...

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of ...

Discover a study showing budesonide–formoterol cuts childhood asthma attacks by 45%, offering a safer alternative to ...

In children aged 5 to 15 years with mild asthma, budesonide-formoterol reliever monotherapy is superior to salbutamol for ...

If budesonide-formoterol were to become available over the counter (OTC) and used as-needed for mild asthma, it would save lives and cut healthcare costs, according to a computer modeling study ...

International asthma guidelines increasingly support the use of inhaled corticosteroid plus fast-acting β-agonist ...

PITTSBURGH and WOODBURY, Minn., July 31, 2023 /3BL/ - Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...